» Authors » Ryu Shimada

Ryu Shimada

Explore the profile of Ryu Shimada including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 496
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsuda K, Hashiguchi Y, Hayama T, Hayashi K, Miyata T, Asako K, et al.
Inflamm Intest Dis . 2024 Mar; 9(1):55-61. PMID: 38529083
Introduction: Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the surgical procedure for ulcerative colitis (UC). Intestinal ischemia may occur if the main blood vessels are ligated at an early...
2.
Asako K, Hayama T, Hashiguchi Y, Miyata T, Fukushima Y, Shimada R, et al.
Anticancer Res . 2023 Mar; 43(4):1563-1568. PMID: 36974804
Background/aim: The clinical significance of many RAS-family mutations in colorectal cancer (CRC) remains unclear. The purpose of this study was to investigate the relationship of RAS mutations on an exon...
3.
Hayama T, Hashiguchi Y, Ozawa T, Watanabe M, Fukushima Y, Shimada R, et al.
Sci Rep . 2022 Mar; 12(1):3682. PMID: 35256659
The world is becoming longer-lived, and the number of elderly colorectal cancer patients is increasing. It is very important to identify simple and inexpensive postoperative predictors in elderly colorectal cancer...
4.
Hayama T, Ozawa T, Tsukamoto M, Fukushima Y, Shimada R, Nozawa K, et al.
In Vivo . 2022 Jan; 36(1):450-457. PMID: 34972748
Aim: It has been shown that nutritional status and inflammation correlate with survival in patients with various cancer types. In this study, we evaluated several kinds of nutritional and inflammation...
5.
Fujii S, Shimada R, Tsukamoto M, Hayama T, Ishibe A, Watanabe J, et al.
Ann Gastroenterol Surg . 2021 Apr; 5(2):228-235. PMID: 33860143
Aim: Stage II-IV colorectal cancers are subdivided according to TNM categories. However, stage I cases are a single category, despite the inclusion of both T1 and T2 cases, which may...
6.
Ozawa T, Matsuda K, Ishihara S, Fukushima Y, Shimada R, Hayama T, et al.
J Surg Oncol . 2021 Apr; 124(1):97-105. PMID: 33848373
Background And Objectives: Most guidelines of colorectal cancers (CRCs) recommend evaluating the serum carcinoembryonic antigen (CEA) level during postoperative surveillance to detect tumor recurrence, which originates from postsurgery residual tumor...
7.
Hayama T, Ozawa T, Asako K, Kondo R, Ono K, Okada Y, et al.
In Vivo . 2021 Feb; 35(2):1261-1269. PMID: 33622929
Background/aim: The prognosis of colorectal cancer is reported to differ depending on the tumor site, and clinical differences depending on the site of occurrence have gained attention. The aim was...
8.
Okada Y, Ozawa T, Hayama T, Ohno K, Tsukamoto M, Fukushima Y, et al.
In Vivo . 2021 Jan; 35(1):593-601. PMID: 33402514
Background/aim: To evaluate the benefits of the addition of oxaliplatin (OX) to fluoropyrimidine (FP)-based neoadjuvant chemoradiotherapy (CRT) for patients with locally advanced rectal cancers (LARCs). Patients And Methods: We performed...
9.
Matsuda K, Okada Y, Hashiguchi Y, Asako K, Ohno K, Tsukamoto M, et al.
Surg Case Rep . 2020 Oct; 6(1):250. PMID: 33001266
Background: Although there are reports linking ulcerative colitis (UC) to prostate cancer (PC), those reports are of PC patients who were previously diagnosed with UC. There are no reports of...
10.
Matsuda K, Hashiguchi Y, Asako K, Okada Y, Ohno K, Tsukamoto M, et al.
Surg Case Rep . 2020 Aug; 6(1):209. PMID: 32797327
Background: Small bowel obstruction (SBO) is a common postoperative complication of ulcerative colitis (UC). There have been a few recent reports of afferent limb syndrome (ALS) as a rare occurrence...